Based on advances in chemical biology and network science, network pharmacology is a distinctive new approach to drug discovery. It involves application of network analysis to determine the set of proteins most critical in any disease, and then chemical biology to identify molecules capable of targeting that set of proteins. By addressing the true complexity of disease and by seeking to harness the ability of drugs to influence many different proteins, network pharmacology differs from conventional drug discovery approaches, which have generally been based on highly specific targeting of a single protein. Network pharmacology has the potential to provide new treatments for complex diseases where conventional approaches have failed to deliver satisfactory therapies.

Long Hanborough, GB
Size (employees)
24 (est)-11%
E-Therapeutics was founded in 2003 and is headquartered in Long Hanborough, GB
Report incorrect company information

E-Therapeutics Office Locations

E-Therapeutics has an office in Long Hanborough
Long Hanborough, GB (HQ)
Blenheim Office Park, 17 Fenlock Rd
Show all (1)
Report incorrect company information

E-Therapeutics Financials and Metrics

E-Therapeutics Financials

E-Therapeutics's revenue was reported to be £67 k in FY, 2009

Net income (FY, 2017)

(13.1 m)

EBITDA (FY, 2017)

(16.3 m)

EBIT (FY, 2017)

(16.3 m)

Market capitalization (31-Oct-2017)

27.2 m

Closing share price (31-Oct-2017)


Cash (31-Jan-2017)

14 m
E-Therapeutics's current market capitalization is £27.2 m.
GBPFY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2015FY, 2016FY, 2016FY, 2017


64 k67 k

Cost of goods sold

24 k5 k

Gross profit

40 k62 k

Gross profit Margin, %

GBPFY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(2 m)(1.5 m)(1.8 m)(2.3 m)(3.2 m)(4.2 m)(5 m)(7.8 m)(8.8 m)(13.1 m)

Cash From Operating Activities

(2.2 m)(1.5 m)(1.7 m)(1.9 m)(3.2 m)(4.2 m)(5.7 m)(9.9 m)(9.2 m)(9.4 m)

Cash From Financing Activities

4.1 m4.4 m82 k16.4 m15 k39 m77 k12 k13 k

Net Change in Cash

1.8 m(1.6 m)2.5 m(2 m)5.2 m(1.9 m)2.7 m(5.1 m)4.5 m(1.9 m)
GBPY, 2017

Financial Leverage

1.1 x
Show all financial metrics

E-Therapeutics Operating Metrics

E-Therapeutics's Projects Launched was reported to be 12 in FY, 2016.
FY, 2015FY, 2016

Projects Launched

6 12
Show all operating metrics
Report incorrect company information